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Abstract Mesenchymal stem cells have been increasingly
introduced to have great potential in regenerative medicine,
immunotherapy, and gene therapy due to their unique proper-
ties of self-renewal and differentiation into multiple cell line-
ages. Studies have shown that these properties may be limited
and changed by senescence-associated growth arrest under
different culture conditions. This study aimed to present the
ability of some growth factors on human umbilical cord mes-
enchymal (hUCM) cells expansion and telomerase activity. To
optimize hUCM cell growth, epidermal growth factor (EGF)
and fibroblast growth factor (FGF) were utilized in culture
media, and the ability of these growth factors on the expression
of the telomerase reverse transcriptase (TERT) gene and cell
cycle phases was investigated. TERT mRNA expression in-
creased in the hUCM cells treated by EGF and FGF. So, the
untreated hUCM cells expressed 30.49±7.15% of TERT,
while EGF-treated cells expressed 51.82±12.96% and FGF-
treated cells expressed 33.77±11.55% of TERT. Exposure of
hUCM cells to EGF or FGF also promoted the progression of
cells from G1 to S phase of the cell cycle and induced them to
decrease the number of cells entering the G2/M phase. Our
study showed that EGF and, to a lesser extent, FGF amplify the
proliferation and expansion of hUCM cells.
Keywords Cell cycle . Growth factors . TERT . Umbilical
cord matrix-derived cells
Introduction
The primitive mesenchymal-like cells of Wharton’s jelly are
trapped at a very early embryological age and retain the
properties of primitive stem cells. They can be more easily
obtained and processed than embryonic and adult mesen-
chymal stem cells (MSC) such as bone marrow-derived and
hematopoietic stem cells (Tamura et al. 2011). These cells
have the ability to self-renew and to differentiate into mul-
tiple cell lineages (Jeon et al. 2011). A necessary factor for
the self-renewal, proliferation, and expansion of these cells
is the maintenance of telomere length (Bayne and Liu 2005;
Jeon et al. 2011). Short telomere length induces the limita-
tion of the cells’ proliferative life span (Chomal 2003).
Shortening of the telomeres can lead to threefold greater
mortality in heart disease, eightfold greater mortality in
infectious disease, and some other problems like coronary
atherosclerosis, vascular dementia, Alzheimer’s disease, and
several cancers (Bayne and Liu 2005). Telomerase, the
enzyme of telomere synthesis (Masutomi et al. 2003), is a
ribonucleoprotein enzyme that synthesizes the telomeric
DNA sequence onto the 3′ ends of chromosomes (Miura et
al. 2001). Telomerase has three subunits, one of them named
telomerase reverse transcriptase (TERT) has an important
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role in the replication of telomere repeat sequences and the
extension of telomere sequence (Wojtyla et al. 2011; Liang
et al. 2012). Cells with higher proliferation capacity such as
cells in Wharton’s jelly can express a high telomerase activ-
ity (Tamura et al. 2011). Considerable evidence suggests
that growth factors such as fibroblast growth factor (FGF),
IGF-1, and epidermal growth factor (EGF) (Maida et al.
2002) are crucially involved in regulating telomerase activ-
ity and gene expression of TERT (Bayne and Liu 2005).
The regulation of telomere length and telomerase activity
is a complex and potent process which leads to cell cycle
regulation in human stem cells (Hulleman and Boonstra
2001). MSCs, after a limited number of cell division in
culture, enter a senescence situation which is considered as
the permanent state of cell cycle arrest (Liang et al. 2012).
Growth factors or signals escape the cells during cell cycle
arrest, so the resting G0 cells prepare themselves for the
process of multiplication in the G1 phase. During passing of
the cells into the S phase, new DNA synthesis takes place
and the cells progress into the G2 phase, which is the
correction process where any aberrations in DNA synthesis
are corrected. Cell proliferation rate is characterized by
greater numbers of cells in the S phase and fewer numbers
of cells in the G0/G1 phase, with G2/M phase cells
remaining constant (Dhulipala et al. 2006). However, in
the absence of growth factors, cells will stop dividing and
enter the quiescent state (G0) (Hulleman and Boonstra
2001).
Investigation about the normal tissue-specific modulators
of the growth factors in regulating telomerase activity and
cell cycle may introduce more specific tools for controlling
the cells’ proliferation and expansion. Therefore, in this
study, the effects of EGF and FGF on TERT expression
and cell cycle stages were investigated on MSCs isolated
from the human umbilical cord.
Materials and Methods
Cell isolation and culture. Mesenchymal cells were isolated
from human umbilical cords using an explant culture ap-
proach as described earlier (Salehinejad et al. 2012a, b).
Briefly, Wharton’s jelly fragments were seeded onto the
surface of a culture dish with Dulbecco’s modified Eagle’s
medium (DMEM)/F12 supplemented with 10% (v/v) fetal
bovine serum (FBS), penicillin (100 U/ml), streptomycin
(100 μg/ml), and amphotericin B (2.5 μg/ml) for 2 wk.
Within this period, every 5 d, half of the medium was
refreshed until the cells migrated from the fragment borders
and reached approximately 80% confluence. From passage
2, human umbilical cord mesenchymal (hUCM) cells were
either used for the experiments or cryopreserved by a con-
ventional freezing protocol using DMSO as cryoprotectant.
Detection of hUCM cells phenotype. Cells were prepared at
a concentration of 1×105 cells/ml in DMEM/F12 with 10%
FBS. The harvested cells were washed, fixed, and incubated
for 15 min at 4°C with a 1:9 dilution of normal goat serum in
PBS to block nonspecific binding of the primary antibody.
The cells were then labeled with the following antibodies:
FITC-conjugated anti-CD34, FITC-conjugated anti-CD44
(Chemicon, Temecula, CA), FITC-conjugated anti-CD45
(eBioscience, San Diego, CA), PE-conjugated anti-CD90
(Dako, Glostrup, Denmark), and PE-conjugated anti-CD105
(R&D, Minneapolis, MN) for 1 h and analyzed using a
FACSCalibur (Becton Dickinson, Franklin Lakes, NJ) ma-
chine. The control population was stained with matched
isotype antibodies (FITC-conjugated and PE-conjugated
mouse IgG monoclonal isotype standards), which were con-
firmed by positive fluorescence of the limbal samples. At least
10,000 events were recorded for each sample and data were
analyzed using WinMDI software (West Lafayette, IN).
Differential capability of hUCM cells. Osteogenic and
adipogenic differentiation of the hUCM cells was carried
out as described elsewhere (Salehinejad et al. 2012a, b). The
cells were cultured in DMEM/F12 medium with either
osteogenic (10 nM dexamethasone, 50 μg/ml ascorbate-
phosphate, and 10 mM β-glycerophosphate) or adipogenic
(100 nM dexamethasone, 50 μg/ml ascorbate-phosphate,
and 50 μg/ml indomethacin) materials for 21 and 14 d,
respectively. Adipogenic differentiation was detected by
Oil Red O staining, while osteogenic differentiation was
detected by Alizarin Red S staining.
Alkaline phosphatase staining. The hUCM cells from the
fourth passage were grown on clean, sterile glass slides for
2–3 wk. The medium was refreshed every 5 d. Alkaline
phosphatase (ALP) activity was detected using an ALP Kit
(R-87 Sigma, St. Louis, MO) according to the manufac-
turer’s instructions. A dark red product after 20 min expo-
sure to the substrate confirmed ALP activity. The cells were
then counterstained with hematoxylin and mounted and
photographed using an Olympus DP71 digital camera at-
tached to an IX71 inverted microscope (Tokyo, Japan).
Treatment of the cells with growth factors. To determine the
effects of EGF and FGF on telomerase activity and cell
cycle phases, the hUCM cells from the fourth passage were
treated with 20 ng/ml EGF or 20 ng/ml FGF for 48 h, while
the control group was incubated only with DMEM/F12
supplemented with 10% FBS. The breast cancer MCF-7
cells, as a positive control, were incubated in DMEM/F12
containing 10% FBS. After 48 h, the cells from each group
were trypsinized and divided into two parts for reverse




RNA isolation and cDNA synthesis. To determine the ex-
pression of TERT gene and housekeeping geneβ-actin, the total
RNA was extracted using Tripure Isolation Reagent (Roche,
Mannheim, Germany). For this purpose, 1 ml/106 cells of
Tripure was used for each of the groups. Subsequently, 0.5–
1 μg of DNase-digested total RNA was used for oligo(dT)
reverse transcription to generate single-stranded cDNA. cDNA
synthesis was completed by using the M-MuLV reverse tran-
scriptase enzyme. The concentration of cDNAwas determined
by measuring the absorbance at 260 nm by using a spectropho-
tometric measurement of ultraviolet (UV) light absorbance.
Semiquantitative reverse transcription polymerase chain
reaction. Semiquantitative RT-PCR assays were performed
with 25 μl reaction mixture for each sample containing
12.5 μl master mix (CinnaGen, Tehran, Iran) including
0.1 U Taq DNA polymerase, 200 μM dNTP, 1.5 μM
MgCl2, 1× PCR buffer, 100 ng MCF-7, hUCMs/EGF, and
hUCMs/FGF cDNA and 200 ng hUCMs cDNA, 2.5 μM
TERT primer (Metabion, Martinsried, Germany) and
0.5 μM β-actin primer (CinnaGen, Tehran, Iran), and
RNase-free water. The conditions used for amplification
were an initial activation step at 94°C for 5 min followed
by 10 cycles of denaturation at 94°C for 30 s, annealing at
65°C for 30 s, and extension at 72°C for 30 s. The first cycle
was followed by 30 cycles of denaturation at 94°C for 30 s,
annealing at 55°C for 30 s, and extension at 72°C for 30 s.
The reaction was completed with a final extension step at
72°C for 10 min. The gene-specific primer sequences,
annealing temperatures, and size of the PCR products are
listed in the Table 1. The PCR products were analyzed using
an ethidium bromide-stained 3% (w/v) agarose gel.
Electrophoresis was then carried out at a voltage of 110 V
for approximately 35 min. When electrophoresis was com-
plete, the gels were visualized on a UV transilluminator and
were photographed. The photographs of the gels were then
scanned using the National Institutes of Health (NIH) image
analysis software (Scion) to determine the density of indi-
vidual bands on the gels. The volume density of the ampli-
fied products was calculated and normalized against the β-
actin housekeeping gene control values.
Cell cycle analysis. Cell cycle was analyzed through
propidium iodide staining. Cultured hUCM cells at three
different conditions and MCF-7 cells were used for cell
cycle analysis. One million cells were incubated with a
solution containing 0.25 g sodium citrate, 0.005 g ribonu-
clease A, 0.025 g propidium iodide, and 0.75 ml Triton X-
100 in 250 ml distilled water at 4°C for 30 min. Cells were
analyzed by FACS, and the proportion of cells in the G0/G1,
S, and G2/M phases was estimated using the FlowJo soft-
ware (version 7.5). The proliferative index (PI) was calcu-
lated according to the following formula, published by
Wang et al. (2007):











Statistical analysis. Statistical analyses were performed
using the SPSS software (version 12.0), and data were
presented as the mean±standard deviation (SD). One-way
ANOVA followed by Tukey’s post hoc test was performed
to compare the data among different groups. All p values<
0.05 were considered significant.
Results
hUCM cells phenotypic. The isolated cells were negative
for the hematopoietic cell surface markers CD34 and CD45;
the expression of CD34 was 13%, whereas the expression of
CD45 was 9%. These cells were positive for the MSC
markers CD44, CD90, and CD105 (99.5%, 57%, and
84%, respectively) (Fig. 1).
Differentiation into adipogenic and osteogenic lineages. On
day 14 of adipogenic treatment, an accumulation of lipid-
containing vacuoles was detected by Oil Red O staining
(Fig. 2a). At day 21, the MSCs became Alizarin Red S-
positive (Fig. 2c). Control cells, maintained in regular me-
dium, showed no Oil Red O-positive or Alizarin Red S-
positive cells (Fig. 2b, d).
Alkaline phosphatase activity. Approximately 14 d after the
onset of culture, the hUCM cells formed colonies which
exhibited ALP activity. The ALP reaction was most intense
within the compactly cell colonies (Fig. 3).
Table 1. Primer sequences, primer annealing temperatures, and sizes of PCR products
Lineage Gene/gene accession number Direction Sequence (5′–3′) Annealing temperature (°C) Amplicon size (bp)
hUCMs TERT Forward CGGAAGAGTGTCTGGAGCAA 59.1 145
Reverse GGATGAAGCGGAGTCTGGA
MCF-7 β-Actin Forward GATGATGATATCGCCGCGCT 55.1 351
Reverse CTTCTCGCGGTTGGCCTTGG
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TERT expression. The 145-bp TERT fragment of various
cDNA was detected in the hUCMs, hUCMs/EGF,
hUCMs/FGF, and MCF-7 groups (Fig. 4A). The 351-bp
internal PCR control was observed in all the groups, which
indicates that none of the samples contained an unusual
amount of Taq polymerase inhibitor (Fig. 4B). MCF-7,
which has been confirmed to be hTERT-positive, expressed
37.33±11.19% of TERT. The untreated hUCM cells
expressed 30.49±7.15% of TERT, while the EGF-treated
cells expressed 51.82±12.96% and FGF-treated cells
expressed 33.77±11.55% of TERT (Fig. 5A). The ratio of
TERT banding to the internal control was also measured.
This ratio was greater in hUCMs/EGF followed by MCF-7
cells, hUCMs, and hUCMs/FGF, respectively (Fig. 5B).
Cell cycle. DNA content analysis revealed that most of the
cells were in the G0/G1 phase in all the growth conditions
(Fig. 6a). Forty-eight hours after stimulation with EGF,
37.34±9.8% of the hUCM cells had entered the S phase,
whereas 26.3±2.55% of the cells treated with FGF and
27.88±8.84% of the untreated cells had done so. Also,
7.71±0.53% of the cells treated with EGF progressed to
the G2/M phase, while 9.58±0.24% of the cells treated with
FGF and 11.31±0.79% of the untreated cells had entered the
G2/M phase. A similar slowing of cell cycle progression
was observed in MCF-7 cells. So, 18.83±6.18% and 1.51±
1.11% of the mentioned cells had entered the S and G2/M
phases, respectively (Fig. 6b). The PI, calculated according
to the formula, was 41.13%, 49.18%, 41.62%, and 22.51%
for hUCMs, hUCMs/EGF, hUCMs/FGF, and MCF-7,
respectively.
Discussion
The extension of telomerase in adult stem cells is still
unclear, and since these are the founder cells of all the
tissues in the body, understanding the expression of telome-
rase in adult stem cells is very important (Serakinci et al.
2008). However, it is certain that, in stem cells, the level of
telomerase activity is not sufficient to maintain telomere
Figure 1. Representative of
flow cytometry results. The red
histograms show the isotype
control-stained cells and the




length during aging (Alenzi et al. 2009). Telomerase de-
creases with the reduction of cell renewal and expansion
potential (Murthy 2002). It was shown that the lack of
telomerase in mouse mesenchymal cells lose multipotency
and the differentiation capacity. These results suggest that,
in addition to its known role in cell replication, telomerase is
required for the differentiation of mMSCs in vitro (Liu et al.
2004). Moreover, studies have shown that, when telomerase
Figure 2. (a) Adipogenic
differentiation in the hUCMCs.
Oil Red O-positive adipocytes
stained as bright orange. (c)
Osteogenic differentiation by
Alizarin Red S-positive calcium
deposition appeared as a red
precipitate. (b, d) No Oil Red
O-positive or Alizarin Red S-
positive cells were detected in
the control samples. Original
magnification, ×100.
Figure 3. The cell colonies
positively stained with ALP (a,
dark red color). Leukocytes of
blood smear as positive control
stained with ALP (b). No ALP-
positive cells were detectable in
hUCMs treated with levamisole
(c). Original magnification,
×200.
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is upregulated at cell cycle entry, somehow the cells prog-
ress through the S phase and they are repressed in quiescent
G0 cells (Murthy 2002). The mechanisms of this association
are unclear, but specific growth factors may be effective on
it. It appears that these growth factors are necessary at the
early stage of the cell cycle at the G1 phase to support the
subsequent DNA replication (Hulleman and Boonstra
2001). So, the present study examined the effect of EGF
and FGF on the telomerase activity and cell cycle of
hUCMs. Our findings showed that EGF caused an increase
in the relative TERT expression and PI.
Unlike most normal somatic cells, which are telomerase-
negative, low to moderate levels of the enzyme have been
described in adult stem cells. But it should be noted that the
absence of telomerase activity in hMSCs, obtained from the
bone marrow, was observed by several investigators
(Stenderup et al. 2003; Zimmermann et al. 2003). These
findings suggest that these cells have a different telomere
biology compared to other adult stem cells. Alternatively,
true MSC might have a very rare subpopulation that has a
detection level below the sensitivity of the telomerase assay
(Zimmermann et al. 2003). On the other hand, the isolated
cells are not homogeneous and a pure cell population; in
reverse, they are a mixture of stem and precursor cells
(Stenderup et al. 2003). Considering these interpretations,
in this study, the explant method was applied for the isola-
tion of mesenchymal cells from Wharton’s jelly since the
cells obtained by the explant method have homogeneous
morphology and the highest cell proliferation compared to
the other methods (Salehinejad et al. 2012a, b).
Besides, the culture method affects the expression of genes.
Gene expression may be more in vivo-like in three-
dimensional culture than in two-dimensional monolayer cul-
tures. For example, tumor antigens may be expressed in three-
dimensional culture and not in monolayer culture (Hoffman
1993). Meanwhile, utilization of Gelfoam as three-
dimensional culture is more current. But, at present, utilization
of Gelfoam is restricted to the investigation of tumors in vitro,
drug response assay, stem cell differentiation (Hoffman 2010;
Duong et al. 2012), or histoculture that can be transplanted to
injured tissue in cell therapy (Hoffman 2010; Liu et al. 2011).
While in our work on hUCMs, we did not need tomaintain the
cells in Gelfoam for forming the actual position of Wharton’s
jelly. At present, more studies use the monolayer culture for
the investigation of these cells. But, future studies utilizing
three-dimensional cultures may significantly enhance our un-
derstanding of gene expression (Hoffman 1993).
In any case, it seems that TERT can express in different
cell conditions with different levels. Comparison of our
Figure 4. RT-PCR assays for β-actin and TERT mRNA expression.
(A) β-Actin as the internal standard expressed in 351 bp and (B) TERT
mRNA expressed in 145 bp. The MCF-7 was used as a positive
control. Each image is the representative of at least three independent
experiments.
Figure 5. hTERT and β-actin expression. (A) hTERT mRNA expres-
sion was detected by RT-PCR compared with β-actin in hUCMs,
hUCMs/EGF, hUCMs/FGF, and MCF-7 (as positive control). There
was no statistically significant difference among the groups (p>0.05).
All data are expressed as the mean±SD, n=3. (B) Relative TERT
expression was assessed by determining the ratio of the TERT band
to the β-actin using the NIH image analysis software (Scion).
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results with Liang et al. (2012) show that TERT was
expressed in hUCM cells at a level of 0.50±0.02 (Liang et
al. 2012), while in our results, hUCMs expressed the TERT
gene at a level of only 0.26±0.06. An interpretation of this
diversity may be that they used whole umbilical cord mes-
enchymal cells, while we used only Wharton’s jelly mesen-
chymal cells.
Certainly, in pluripotent stem cells, which are telomerase-
positive (Young and Black 2004), the high concentrations of
trophic growth factors, such as EGF, aFGF, and bFGF
(Majore et al. 2011), cause high expansion of the cells.
Growth factors such as EGF directly regulate telomerase
via specific signal transduction pathways (Maida et al.
2002). Budiyanto et al. (2003) have demonstrated that
EGF activates TERT in NIH3T3 and A431 cells, whereas
EGF cannot increase TERT in HSC-1. However, when
hTERT-negative normal cells (normal foreskin fibroblasts
or endometrial stromal cells) were treated with EGF, no
induction of hTERT mRNA expression was observed.
Thus, the effect of EGF is limited to telomerase-positive
cells which constitutively express hTERT and does not
apply to hTERT-negative cells (Maida et al. 2002).
Our results showed that the presence of EGF considerably
promoted the expression level of TERT (from 30.49±7.15% to
51.82±12.96%), so that TERT was expressed more than our
positive control cells (MCF-7) (37.33±11.19%). ES cells treat-
ed with FGF-2 expressed TERT for a long term (Schwob et al.
2008). The findings show that the presence of FGF in culture
may lead to different expression levels of TERT. In this re-
search, it was found that, in the presence of FGF, TERT is
expressed only slightly higher than the absence of FGF (from
30.49±7.15% to 33.77±11.55%). Considering that the usage
of FGF-2 with a lower dose causes stimulation of cell prolifer-
ation and a higher dose leads to cell differentiation (Garcia et al.
2005), it seems that the FGF dosage used in this study was
inadequate for cell proliferation, which needs further research.
Investigation of cell cycle phases is another aspect of the
cell expansion survey. Both intracellular and extracellular
Figure 6. (a) Representative of the flow cytometry results of the cell
cycle and (b) distribution of the cells in the different phases of the cell
cycle. In all of the groups, a higher percentage of the cells are in the
G0/G1 phase. The cell percentage in the S/G2/M phase was higher in
hUCMs/EGF, hUCMs/FGF, hUCMs, and MCF-7 respectively. All data
are expressed as the means±SEM, n=3.
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control mechanisms are used for the regulation of cell cycle
progression, but extracellular factors may determine cell fate
such as differentiation, proliferation, or apoptosis. Cell cycle
progression depends on the presence of growth factors. As
long as growth factors are present, most adherent cells will
continue their proliferation (Hulleman and Boonstra 2001).
Cell cycle analysis has revealed that the DNA content of
most of the cells is higher in the G1 phase (Seshareddy
2008). However, some of the determining properties of ES
cells are that they can be induced to continue proliferating or
differentiating, they lack the G1 checkpoint in the cell cycle,
and they spend most of their time in the S phase of the cell
cycle, whereas cell cycle analysis have demonstrated that
more than 80% of umbilical cord-derived cells (P2 to P6)
are in the G0/G1 phase (90.0±0.4%) and only a small
proportion of cells are engaged in proliferation (G2/M
phase, 6.0±0.3%; S phase, 4.0±0.7%) (Cao and Feng
2009). Liang et al. (2012) have shown that hUCMs are
84.0±2.4% in the G0/G1 phase, 7.7±0.9% in the S phase,
and 8.3±1.5% in the G2/M phase. Also, Zeng et al. (2011)
got similar results as the hUCMs they used were 80.03±
4.28% in the G0/G1 phase, 18.45±4.10% in the S phase,
and 1.52±0.57% in the G2/M phase. Another report has
indicated that 60±2.9% of hUCM cells were located in the
G0/G1 phase, 8.9±1.6% in the S phase, and 31.1±1.3% in
the G2/M phase of the cell cycle at the same time (Majore et
al. 2011). Our results were closer to the results of Majore et
al. (2011) that 56.09±6.56% of the hUCMs located in the
G0/G1 phase, while the percentage of cells located in the S
and G2/M phases were slightly different from the others
(27.88±8.84% and 11.31±0.79%, respectively). The PI for
hUCMs calculated by Liang et al. (2012) was 16±2.4, while
in our study, the PI was calculated as 41.13% for hUCMs
and 22.51% for MCF-7cells, as positive control, which was
a considerable finding.
The end of the G1 phase or restriction point (R) has been
defined as the point in G1 and the time that the cells no
longer respond to the withdrawal of growth factors because,
when the cells pass the restriction point, they will continue
cell cycle progression independent of the presence of
growth factors and enter the S phase. So, it seems that
limited exposure of the cells to growth factors is enough
for cell proliferation and when growth factors are removed
before the restriction point. In our experiments, we kept the
cells for 48 h in the presence of EGF and FGF (Hulleman
and Boonstra 2001)
On the bases of the cell type, EGF causes diverse effects
on cell growth (Maida et al. 2002). When Liang et al. (2010)
exposed the hUCMs to EGF, after 24 h, 68.66±3.43 of cells
were in the G0/G1 phase, while 11.0±0.55 and 20.34±1.02
were in the S and G2/M phases, respectively (Liang et al.
2010). It was shown that, via using EGF, after 21 h of
treatment with 5 ng/ml EGF, the G1/G0 phase ratio of
MCF10A cells moved from 78% to 42% and the S phase
increased from 1% to 20% and the G2/M phase changed
from 21% to 38% (LeVea et al. 2004). On the other hand,
the PI in these cells progressed from 31% to 58%. Cell cycle
analysis on our cells after exposure to EGF for 48 h showed
that 46.55±6.25% of cells remained in the G0/G1 phase,
while 37.34±9.8% and 7.71±0.53% of cells moved to the S
and G2/M phases, respectively. So, it can be concluded that
EGF has the ability to increase the PI from 41.13% to
49.18%; besides this, it can facilitate the progression of cells
from G1 to S phase.
FGFs are usually used at lower doses (Garcia et al. 2005)
in cell cultures for the propagation of hUCMs (Gauthaman
et al. 2010). Upadhyay et al. (2007) showed that FGF-10
protects the cells against oxidant-induced DNA damage and
apoptosis, so they focused on examining the effect of FGF-
10 on A549 cells in the G1 phase. The rate of cell prolifer-
ation is normally controlled by the duration of the G1 phase
of the cell cycle (Zhu et al. 1996). Cell cycle analysis of
AEC revealed that 92.2% of the examined cells were in the
G0/G1 phase, with 5.43% in the S phase and 2.37% in the
G2/M phase. Following exposure to 10 ng FGF-10, 44.1±
2.9% of the treated cells moved to the S/G2/M phase, while
56.9±2.1% of the cells remained in the G0/G1 phase
(Upadhyay et al. 2007). We found similar results in this
study, so that 41.62% of hUCM cells exposed to FGF were
in the S/G2/M phase.
Conclusion
We may conclude that growth factors amplify the prolifer-
ation and expansion of hUCM cells. So that EGF caused the
increase in the expression levels of TERT in these cells. We
also conclude that the ratio of hUMCs in the G0/G1 phase
decreased, while those in the S/G2/M phase increased after
EGF and FGF treatments.
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